Bogart Wealth, LLC Genmab A/S Transaction History

Bogart Wealth, LLC

$2.1 Billion
Q3 2024

A detailed history of Bogart Wealth, LLC transactions in Genmab A/S stock. As of the latest transaction made, Bogart Wealth, LLC holds 146 shares of GMAB stock, worth $3,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares

146

Holding current value

$3,006

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 22, 2024	BUY	$23.84 - $28.48 $3,480 - $4,158	146 New	146 $3,000
Q3 2023 Oct 30, 2023	BUY	$35.27 - $42.24 $1,763 - $2,112	50 New	50 $1,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.

Account